Back
AVITA Medical 10K Form
Sell
25
RCEL
AVITA Medical
Last Price:
8.74
Seasonality Move:
1.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RCEL News And Ratings
See the #1 stock for the next 7 days that we like better than RCEL
RCEL Financial Statistics
Sales & Book Value
| Annual Sales: | $50.14M |
|---|---|
| Cash Flow: | $-11.19M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.91 |
| Price / Book: | 4.58 |
Profitability
| EPS (TTM): | -1.40000 |
|---|---|
| Net Income (TTM): | $-35.38M |
| Gross Margin: | $42.36M |
| Return on Equity: | -51.58% |
| Return on Assets: | -37.65% |
AVITA Medical Earnings Forecast
Key AVITA Medical Financial Ratios
- The Gross Profit Margin over the past 20 years for RCEL is 84.48%.
- The Selling, General & Administrative Expenses for RCEL have been equal to 130.88% of Gross Profit Margin.
- The Research & Development expenses have been 41.52% of Revenue.
- The Interest Expense is -3.23% of Operating Income.
- The Net Earning history of RCEL is -70.56% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 13 years.
AVITA Medical Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RCEL |
| Website: | avitamedical.com |
Debt
| Debt-to-Equity Ratio: | 0.81 |
|---|---|
| Current Ratio: | 7.88 |
| Quick Ratio: | 7.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RCEL Technical Analysis vs Fundamental Analysis
Sell
25
AVITA Medical (RCEL)
is a Sell
Is AVITA Medical a Buy or a Sell?
-
AVITA Medical stock is rated a Sell
The current AVITA Medical [RCEL] share price is $8.74. The Score for RCEL is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.